Glycoproteinosis

Description

These are lysosomal storage diseases affecting glycoproteins, resulting from defects in lysosomal function. The term is sometimes reserved for conditions involving degradation of glycoproteins.

Exclusions from above levels

5C51.3 – Glycogen storage disease due to LAMP-2 deficiency
http://id.who.int/icd/entity/1191191920 – Disorders of lipoprotein metabolism or certain specified lipidaemias
3A10.Z – Hereditary haemolytic anaemia due to enzyme deficiency

Show allHide

5A71.01 – Congenital adrenal hyperplasia
5A81.1 – 5-alpha-reductase deficiency
LD28.01 – Marfan syndrome
LD28.1 – Ehlers-Danlos syndrome
LD2A.4 – androgen resistance syndrome
18 – Pregnancy, childbirth or the puerperium
http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Child codes

5C56.20 – Mucolipidosis
5C56.21 – Oligosaccharidosis
5C56.2Y – Other specified glycoproteinosis
5C56.2Z – Glycoproteinosis, unspecified

Sibling codes

5C56.0 – Sphingolipidosis
5C56.1 – Neuronal ceroid lipofuscinosis
5C56.3 – Mucopolysaccharidosis
5C56.4 – Disorders of sialic acid metabolism
5C56.Y – Other specified lysosomal diseases
5C56.Z – Lysosomal diseases, unspecified

Foundation entity

Glycoproteinosis – http://id.who.int/icd/entity/979972142

Part of: 5C56: Lysosomal diseases › 05: Endocrine, nutritional or metabolic diseases